Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments.
Qinhao Pharmaceutical is harmaceutical enterprises with a gathering of humanities and innovation.
Vivere develops targeted cancer therapies that activate the immune system to detect and destroy tumors using engineered bio-platforms.
Cryofocus Biotech cryoablation device manufacturer.
Essentia Biosciences is a biotechnology company that specializes in development of cells, gene technology drugs and medical devices.
Degron Therapeutics is a platform company in discovery of molecular glue degraders for cancer treatment.
Jiajin Biotech is a pharmaceutical R&D service provider.
Lingtai Biotechnology is a pharmaceutical and biotechnology based company that develops targeted protein degradation drugs.
Allink Biotherapeutics is a biopharmaceutical company that develops multi-specific antibodies for oncology and immunology treatment.
KYinno is a drug development company that is dedicated to oncology drug development with a focus on immune treatments against cancer.
Afference is an electronics manufacturing company that offers wearables that enable the digital dexterity of 3D digital content.
Xingyuanzhi Robotics is a company focused on the development of universal embodied brain technology.
Psivant Therapeutics is a biotechnology company that offers drug design, biology research, and development services.
Hengyu Medical is a medical device firm focused on R&D and production of IVUS and optical coherence tomography, and catheter equipment.
AnyiPu is a leading Chinese high-tech company focused on chemical analysis and medical testing instruments.
Developing Cell Therapies for Degenerative Diseases.
Reprogenix is a groundbreaking medical technology firm
Junsai Shengwu is a biotechnology company that develops novel therapeutic approaches for new solid tumor cell .
Shenzhen CardioACC Ltd specializes in advanced cardiovascular interventional, natural cavity imaging and advanced diagnostic procedures.
Hyperway Pharm IS A Pharmaceutical research and development production enterprise
Pelage Pharma is a regenerative medicine biotechnology company developing treatments for hair loss.
AeroRx Therapeutics is a biopharmaceutical company that developing proprietary, combination products.
OncoC4 is a biopharmaceutical company that engages in the discovery and development of novel biologicals for cancer treatment.
AusperBio is a biotechnology company that develops innovative drugs for curing chronic hepatitis B and other major infectious diseases.
BioVenture has invested in 274 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
BioVenture's top investment sectors include Biotechnology, Health Care, Pharmaceutical, Biopharma, Medical. The firm invests across 21 different industry categories.
Among tracked funding rounds, Pelage Pharmaceuticals received $120.0M in a Series B round. BioVenture's total known invested capital is $1.0B.
BioVenture's average investment size is $20.1M across its portfolio of 274 companies.
Recent BioVenture portfolio additions include XellSmart, Qinhao Pharmaceutical, Vivere Oncotherapies, Cryofocus Biotech, Essentia Biosciences. These companies were founded in 2020 or later.